The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias

Cellular Signalling
Ajith A WelihindaEdward P Amento

Abstract

Inosine is an endogenous purine nucleoside that is produced by catabolism of adenosine. Adenosine has a short half-life (approximately 10s) and is rapidly deaminated to inosine, a stable metabolite with a half-life of approximately 15h. Resembling adenosine, inosine acting through adenosine receptors (ARs) exerts a wide range of anti-inflammatory and immunomodulatory effects in vivo. The immunomodulatory effects of inosine in vivo, at least in part, are mediated via the adenosine A2A receptor (A2AR), an observation that cannot be explained fully by in vitro pharmacological characterization of inosine at the A2AR. It is unclear whether the in vivo effects of inosine are due to inosine or a metabolite of inosine engaging the A2AR. Here, utilizing a combination of label-free, cell-based, and membrane-based functional assays in conjunction with an equilibrium agonist-binding assay we provide evidence for inosine engagement at the A2AR and subsequent activation of downstream signaling events. Inosine-mediated A2AR activation leads to cAMP production with an EC50 of 300.7μM and to extracellular signal-regulated kinase-1 and -2 (ERK1/2) phosphorylation with an EC50 of 89.38μM. Our data demonstrate that inosine produces ERK1/2-biased s...Continue Reading

References

Oct 1, 1988·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J W PhillisG A Walter
Apr 1, 1988·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J W PhillisG A Walter
Dec 1, 1987·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J W PhillisR E Stair
Feb 12, 1998·The Journal of Clinical Investigation·X JinJ Linden
Oct 24, 2001·American Journal of Respiratory and Critical Care Medicine·L LiaudetC Szabó
Oct 22, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·J G MableyA L Salzman
Oct 31, 2002·The Journal of Investigative Dermatology·Stefania MerighiPier Andrea Borea
Jul 2, 2003·Cellular Signalling·Gunnar Schulte, Bertil B Fredholm
Dec 31, 2003·Trends in Immunology·György Haskó, Bruce N Cronstein
Jan 31, 2004·British Journal of Pharmacology·Renée Germack, John M Dickenson
Mar 17, 2004·Trends in Pharmacological Sciences·György HaskóCsaba Szabó
Jan 6, 2006·The Journal of Trauma·Daniel N Darlington, Donald S Gann
Dec 17, 2008·Endocrine, Metabolic & Immune Disorders Drug Targets·J Ham, D A Rees
May 18, 2010·The Journal of Pharmacology and Experimental Therapeutics·Francisney P NascimentoAdair Roberto Soares Santos
Mar 12, 2011·Science·Fei XuRaymond C Stevens

❮ Previous
Next ❯

Citations

Jul 2, 2016·Journal of Neurochemistry·Rodrigo A Cunha
Oct 19, 2016·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kenneth A Jacobson, Mortimer M Civan
Apr 13, 2017·Expert Review of Anticancer Therapy·Theresa L Whiteside
Jan 6, 2018·Nature Reviews. Drug Discovery·Jeffrey S SmithSudarshan Rajagopal
Mar 6, 2019·Current Pharmaceutical Design·Mohammed Nooraldeen Mahmod Al-Qattan, Mohd Nizam Mordi
Mar 28, 2019·Pharmacological Reviews·Terry Kenakin
Dec 6, 2018·International Journal of Molecular Sciences·Kevin SekPaul A Beavis
Jul 12, 2017·Journal of Neural Transmission·Filipe Marques GonçalvesRodrigo Bainy Leal
Jun 17, 2020·Neuroscience Bulletin·Bruno G Frenguelli, Nicholas Dale
Dec 15, 2016·Purinergic Signalling·Filipe Marques GonçalvesRodrigo Bainy Leal
Mar 27, 2020·Frontiers in Endocrinology·Andrea Bast-Habersbrunner, Tobias Fromme
Jun 10, 2020·Nature Reviews. Clinical Oncology·Bertrand AllardJohn Stagg
Oct 26, 2018·Circulation Research·Jialu WangHoward A Rockman
Dec 29, 2020·Biochemical Pharmacology·Eduardo R Lazarowski, Richard C Boucher
Dec 15, 2020·International Journal of Biological Macromolecules·Naveen Narayanan, Deepak T Nair
Dec 14, 2019·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Hyung-Suk YoonDanxia Yu
Feb 22, 2021·Cellular Signalling·Samantha M McNeillLauren T May
Jul 25, 2020·International Journal for Parasitology·Benjamin AmericusStephen D Atkinson
Mar 30, 2021·Early Intervention in Psychiatry·Shusuke UekusaTakeshi Fukushima
Oct 16, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Barbara Kutryb-ZajacRyszard T Smolenski
Jun 24, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lisa EhlersTimo Gaber
Jul 4, 2021·Biochimica Et Biophysica Acta. Biomembranes·J SchachterP J Schwarzbaum
Aug 20, 2021·Frontiers in Immunology·Gilda VarricchiGiuseppe Spadaro
Oct 1, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Marianna LovásziGyörgy Haskó
Dec 21, 2021·ACS Pharmacology & Translational Science·Ines L ParaisoJan F Stevens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here